Product Name: SJ GKOE

Net Weight: 250mg x60 capsules/bottle

Bottle Ingredient: Folium Ginkgo Biloba Extract

Direction of Use: Take 1- 2 Capsules daily, Adjust usage according nutritional lifestyle requirements.  

Suitable For: Suitable for everyone.
Why has SJ GKOE CAPSULE 's Thrombolysis Technology Achieved Such Breakthroughs？
In 2010, the R&D team at Super J Marketing Sdn Bhd successfully developed the innovative SJ GkOE Capsule, a thrombolytic agent. Using American nanotechnology, the capsule extracts a crucial microprotein — a hydrolyzed microthrombolytic enzyme — from Japanese ginkgo biloba. It primarily functions to catalyze protein decomposition and promote the dissolution of fibrin (blood clots) in the bloodstream, thereby achieving a "thrombolytic" effect. It is also known as a fibrinolytic enzyme and has significant potential for treating cardiovascular diseases such as myocardial infarction and cerebral thrombosis. It can literally save blood vessels! It can be a lifesaver for patients with cardiovascular disease.
The thrombolytic microenzymes in SJ GkOE Capsules reveal many secrets worth exploring. These enzymes effectively prevent vascular diseases, control disease progression early on, and treat and prevent thrombus formation. This field has many potential applications. A cure will be found in the future!

SJ GK-OE Capsule: The Only Formula to Keep You Free from Cardiovascular Disease. 
The 21st century is the era of nutritional medicine. Many scientists are using natural thrombolytic microenzyme therapy to transform nutrients into safe medications that can prevent vascular diseases, guard against disorders, and combat cancer. From now on, people will no longer despair! The most common cardiovascular conditions among the 487 vascular diseases are hypertension, coronary heart disease, angina pectoris, sudden cardiac death during exercise, acute myocardial infarction, dyslipidemia, hyperlipidemia, stroke, erectile dysfunction, and Parkinson's disease.
The thrombolytic microenzymes in SJ GkOE Capsules show great promise, making further research worthwhile. These enzymes effectively prevent the progression of vascular disease and proactively manage conditions. They also provide clinical treatment and thrombosis prevention. There is hope for those affected by these diseases! Once-untreatable heart and cerebrovascular diseases can now be reversed with these microenzymes. Coronary heart disease, for example, is the most prevalent of the 487 types of cardiovascular diseases. The greatest challenge lies in the irreversibility of damaged heart cells once they harden and die. 
Current drug therapies can only slow progression — they cannot restore damaged myocardium to its original state. Cancer and organ necrosis! Fortunately, a new treatment option is now available.
SJ GKOE Capsule Thrombolytic Microenzyme Therapy: A Breakthrough in 21st-Century Thrombolysis
•Its primary function is to completely dissolve blood clots.
Now, let's examine its thrombolytic mechanism. 
•The first approach is: Direct thrombolysis degrades fibrin directly and targets thrombolysis. Specifically, it hydrolyzes fibrin, the primary component of blood clots. The microenzymes in the SJ GKOE capsule disrupt the structure of fibrin, disintegrating clots and restoring blood circulation. As previously discussed, the scaffold structure of thrombi is cross-linked fibrin. Therefore, the thrombolytic enzyme in the capsule dissolves this scaffold, achieving thorough, targeted dissolution.
• Second approach: Indirect Thrombolysis as an Adjunct
1) This involves activating plasminogen to convert it into plasmin.
2) The urokinase precursor is activated to convert it into urokinase.
Our bodies naturally contain plasminogen and urokinase precursors, but they must be converted into enzymes to become active.
The thrombolytic microenzymes in SJ GkOE capsules convert plasminogen and urokinase proenzymes into their active enzyme states, enabling them to function normally.
3) The capsule inhibits plasminogen activator inhibitors by degrading and deactivating plasminogen activator inhibitor-1 (PAI-1). This regulates fibrinolysis.
4) The capsule also stimulates the vascular endothelium to produce tissue plasminogen activator (tPA), which activates plasminogen into fibrinolytic enzymes and stimulates the production of more tPA, primarily activating the conversion of plasminogen.
•The second function is to promote microcirculation throughout the body. In addition to large and small blood vessels, the human body contains capillaries, which are even smaller. Imagine a large tree. The trunk represents the arteries and veins, and the branches represent the microcirculatory system. Every cell and organ relies on this vascular network to deliver oxygen and nutrients and remove waste. When blood becomes impure, it is the capillaries—the smallest vessels—that clog first.

What does SJ GKOE do in our body?
SJ GKOE forms a biomolecular complex with thrombin via its acidic C-terminus and thereby prevents the activity of thrombin. SJ GKOE has been produced plant synthetically and used in the treatment of deep vein thrombosis and for coronary angioplasty reparation.


What is SJ GKOE produced from?
The value of Medical knowledge is the development of the recombinant pharmaceutical enzyme Ginkgo, a potent anticoagulant derived from the element of Ginkgo.

What is  SJ GKOE two uses of anticoagulant?
SJ GKOE-anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks. A blood clot is a seal created by the blood to stop bleeding from wounds.

What does SJ GKOE prevent?
SJ GKOE produce an enzyme in Ginkgo elements,and is a powerful anticoagulant. They produce this to prevent their host from forming a clot

Who is suitable to take SJ GKOE ?
SJ GKOE specifically targets, prevents and dissolves the formation of clots . . . It is commonly used to treat other blood coagulation disorders, skin hematomas, and superficial varicose veins.